Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Questex’s Fierce Life Sciences Announces the 2026 Partnerships with Sites Summit Agenda

globenewswire.com
LLY Eli Lilly is mentioned as a participant in the Partnerships with Sites Summit, an event focused on clinical trial sites and patient enrollment. No specific performance or outlook is discussed. BIIB Biogen is listed as a participant in the Partnerships with Sites Summit, an event focused on clinical trial sites and patient enrollment. The article does not provide any sentiment regarding the company's performance or prospects. AZN AstraZeneca is mentioned as a participant in the Partnerships with Sites Summit, an event focused on clinical trial sites and patient enrollment. The article does not offer any specific sentiment about the company. BMY BMS (Bristol Myers Squibb) is mentioned as a participant in the Partnerships with Sites Summit, an event focused on clinical trial sites and patient enrollment. No specific sentiment is expressed about the company. MRK Merck is listed as a participant in the Partnerships with Sites Summit, an event focused on clinical trial sites and patient enrollment. The article does not provide any sentiment regarding the company's performance or prospects. TEVA Teva is mentioned as a participant in the Partnerships with Sites Summit, an event focused on clinical trial sites and patient enrollment. The article does not offer any specific sentiment about the company.

Questex’s Fierce Life Sciences Announces the 2026 Partnerships with Sites Summit Agenda NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- Questex’s Fierce Life Sciences today announces the Partnerships with Sites Summit agenda. The 2 nd annual Summit takes place September 14, 2026, at the Sheraton Boston Hotel.

The Summit brings together clinical trial sites, sponsors, and CROs to address the critical challenge in clinical research: improving patient enrollment by focusing on operational realities and partnership strategies that enable scalable, high-performing collaboration across the ecosystem.

“The time is now, as sites face increasing burden, protocols grow more complex, and the demand for trials continues to rise,” said Kate Woda, Senior Director, Partnerships with Sites Summit. “Partnerships with Sites focuses on what sites need to succeed and how to rebuild the ecosystem to support better patient enrollment.”

The Summit features multi-stakeholder participation, including leaders from organizations such as Eli Lilly, Biogen, Boehringer Ingelheim, AstraZeneca, Novartis, BMS, Takeda, Merck, Teva, Keenova, Sanofi and more.

The program addresses:

Additional speakers will be announced in the coming weeks.

Partnerships with Sites will be followed by DPHARM: Disruptive Innovations to Modernize Clinical Research, taking place September 15–16.

To learn more about Partnerships with Sites and to register to attend, please visit partnershipswithsites.com.

For sponsorship opportunities, contact Brandon Pepper at bpepper@questex.com.

About Fierce Life Sciences

Fierce Life Sciences offers a full suite of news, analysis and event education, all in one place. From preclinical research to market and beyond, our team of editors and handpicked experts deliver insights you can source with confidence and events, both virtual and live, that support professional and business growth.

About Questex

Questex fuels exceptional business connections—where every buyer and seller interaction matters. Through live events enriched with data insights and active year-round digital communities, we deliver measurable results. It happens here.

Media Contact

Alaina Schwartz

Partnerships with Sites Summit

aschwartz@questex.com